CARN-AP study plan

Map DSM-5-TR diagnostic criteria, course specifiers, and severity thresholds for the major substance classes into a single comparison grid

Distinguish physiological tolerance and withdrawal from pseudoaddiction, pseudotolerance, and drug-seeking behavior using vignette-based reasoning

Score three standardized screening instruments (AUDIT-C, DAST-10, CRAFFT) and justify each cut score against age, pregnancy, and chronic-pain population norms

Explain how substance-induced presentations confound brief cognitive and mental status screening, and name two follow-up assessments for each confound

Apply DSM-5-TR temporal criteria to separate substance-induced from independent mood, anxiety, and psychotic disorders in at least four cases

Stage withdrawal severity using CIWA-Ar and COWS scoring, and state the threshold at which each scale triggers a higher level of care

Build a laboratory interpretation reference that states detection windows for urine drug screen immunoassays, ethyl glucuronide, phosphatidylethanol, and carbohydrate-deficient transferrin

Conduct a structured diagnostic interview and document a complete mental status examination from a standardized patient transcript

Compare buprenorphine, methadone, and extended-release naltrexone on induction strategy, target dose, monitoring parameters, and contraindications

Select and justify pharmacotherapy for alcohol use disorder (naltrexone, acamprosate, disulfiram, topiramate) against hepatic, renal, and adherence considerations

Identify clinically significant drug interactions and boxed warnings across the addiction pharmacopeia, including sedative co-prescribing and QT-prolonging combinations

Design a monitored benzodiazepine taper for a patient maintained on an opioid agonist, specifying cross-tolerance assumptions and safety checkpoints

Match medication choice to comorbid conditions (hepatic impairment, pregnancy, chronic pain, bipolar disorder) across five clinical scenarios

Demonstrate motivational interviewing microskills (open questions, affirmation, reflection, summary) and differentiate change talk from sustain talk in a recorded session

Integrate overdose-prevention education and naloxone distribution into routine medication management teaching

Explain adherence supports and retention strategies that improve medication persistence during the first 90 days of treatment

Deliver core CBT-relapse-prevention components (functional analysis, high-risk situation planning, coping-skills rehearsal) in a structured session outline

Describe contingency management principles and the scheduling and magnitude parameters that make reinforcers effective

Determine level of care for three vignettes using the ASAM Criteria dimensions and documented rationale

Draft a warm-handoff referral that specifies clinical information shared, consent obtained, and expected follow-up interval

Differentiate the roles of prescriber, nurse, counselor, peer recovery specialist, and pharmacist in a shared treatment plan

Distinguish 42 CFR Part 2 protections from HIPAA requirements and state the consent elements needed before releasing substance use disorder treatment records

Design a SBIRT workflow for a primary care or emergency setting, naming who screens, who briefs, and who refers

Apply harm-reduction strategies (naloxone co-prescribing, syringe services, safer-use counseling, fentanyl test strips) to three risk profiles

Map recovery-support options including mutual-aid models, peer recovery coaching, and recovery housing, with referral criteria for each

Specify preventive care gaps common in this population, including hepatitis C and HIV screening, vaccination status, and dental and prenatal care linkage

Analyze informed consent, confidentiality limits, and minor-consent rules across four ethical vignettes and reach a defensible course of action

State mandated-reporting and duty-to-warn obligations and where they intersect with confidentiality protections in substance use treatment

Identify boundary, dual-role, and impaired-practice concerns in advanced practice addiction nursing, including self-reporting and peer-review pathways

Verify current federal and state requirements for prescribing controlled substances for opioid use disorder, including registration, documentation, and prescription monitoring program checks

Evaluate telehealth-delivered addiction care against licensure, privacy, and standard-of-care expectations

Complete a full-length timed practice examination under test-day conditions and record item-level performance by domain

Re-teach every missed item back to the underlying concept and classify each error as knowledge gap, misread stem, or reasoning error

Run spaced-retrieval review of the medication matrix, screening cutoffs, withdrawal scales, and confidentiality rules

Assemble a one-page rapid-review sheet covering the highest-yield facts from all six domains